Hematology/Oncology/BMT

Two Investigational Antitumor Agents Work Better Together Against MPNST and Neuroblastoma

The synergistic effects of a kinase inhibitor and an oncolytic herpes virus show promise for difficult-to-treat neuroblastomas and malignant peripheral nerve sheath tumors.
February 2, 2017  |  Written by